Inflammation in Cancer: A Target for Prevention and Therapy 2.0
A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Cell Biology".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 508
Special Issue Editors
Interests: pharmacological characterization of new antitumoral drugs of chemical or natural origin; inflammation and cancer; role of prostaglandins in tumor progression and angiogenesis; tyrosine kinase receptor activity in tumor progression and angiogenesis; characterization of novel molecules with pro- and anti-angiogenic activity; molecular mechanisms underlying CCM pathogenesis; physio-pathological functions of KRIT1 protein and its signaling pathways
Special Issues, Collections and Topics in MDPI journals
Interests: antioxidant; anti-inflammatory; antitumoral activity; natural compounds; nutraceutical applications; cerebral cavernous malformation; KRIT1
Special Issues, Collections and Topics in MDPI journals
Interests: inflammatory disorders, breast cancer, and cancer-related-inflammation; preclinical and translational studies aimed at characterizing the role of NAD metabolism in the progression of cancer and inflammatory bowel disorders (IBD), in particular in studing the pathogenesis and progression of IBD and breast cancer at the molecular level; role of iNAMPT/eNAMPT in the progression and/or pathogenesis of breast cancer and IBD; pharmacological inhibition of the extracellular form of NAMPT (eNAMPT) using monoclonal antibodies in inflammatory disorders and cancer; pharmacological characterization of new antitumoral drugs (e.g., IDO inhibitors) of chemical origin and novel neutralizing antibodies; characterization of novel molecules as a drug with anti-inflammatory activity; study of novel biomarkers for clinical prediction of biological drug responses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This collection is the second edition of the previous one, "Inflammation in Cancer: A Target for Prevention and Therapy".
Chronic inflammation is a critical component of tumor progression and pathogenesis. Several inflammatory diseases increase the risk of cancer, and moreover, the activation of a pathway promoting inflammatory cytokine production and inflammatory cell recruitment is observed in tumors that are not directly related to an inflammatory condition.
Several questions related to the role of inflammation in molecular mechanisms and in tumor development are still unresolved.
In this Special issue, we aim to produce a collection of the latest progress associated with the role of inflammatory pathways in the development and progression of different tumors. Findings should provide insights into how inflammation can influence cell transformation, tumor formation, and metastasis and elucidate the therapeutic implications and effects given by modulating inflammatory signaling pathways.
Dr. Federica Finetti
Dr. Lorenza Trabalzini
Dr. Cristina Travelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- cyclooxygenase 2
- microsomal prostaglandin E synthase 1
- cancer
- epithelial mesenchymal transition
- biomarkers
- immunotherapy
- metabolism
- myeloid and lymphoid cells
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Inflammation in Cancer: A Target for Prevention and Therapy in Biology (6 articles)
